Outcomes and Characteristics of Mesenchymal Tumors Involving the Parotid Gland.

IF 1.3 4区医学 Q3 OTORHINOLARYNGOLOGY

Annals of Otology Rhinology and Laryngology Pub Date : 2025-05-15 DOI:10.1177/00034894251336840

Hannah Q Baratz, Linda X Yin, Eric J Moore, Jeremy Molligan, Kendall K Tasche, Kathryn Van Abel, Daniel L Price

{"title":"Outcomes and Characteristics of Mesenchymal Tumors Involving the Parotid Gland.","authors":"Hannah Q Baratz, Linda X Yin, Eric J Moore, Jeremy Molligan, Kendall K Tasche, Kathryn Van Abel, Daniel L Price","doi":"10.1177/00034894251336840","DOIUrl":null,"url":null,"abstract":"Background: Malignant mesenchymal tumors involving the parotid gland are uncommon, characteristically aggressive, and little is known with few reports documented.Study design: Retrospective case series.Setting: Single institution tertiary care center, 2010 to 2022.Method: Patients were identified from an institutional parotid tumor database. Patient history, demographics, pathologic diagnosis, treatment, and follow up were documented.Results: Eight patients were identified, 3 were males. The average age was 61 years old, and the most common tumors identified were pleomorphic sarcomas (3 patients). Presenting symptoms included: preauricular/cheek mass in 7 patients, facial pain (4), otalgia (4), aural fullness (3), and numbness (1). All patients received a parotidectomy, and 4 patients received adjuvant therapy of either radiation or chemoradiation. Post-operatively, there were 3 cases of distant recurrence, 2 cases of regional recurrence, and 1 case of local recurrence. There were 2 reports of death.Conclusion: Malignant mesenchymal tumors of the parotid are rare, represent varied histologies. Due to their aggressive nature, surgical resection with radiation and close follow-up may be an appropriate treatment regimen in controlling the disease.","PeriodicalId":50975,"journal":{"name":"Annals of Otology Rhinology and Laryngology","volume":" ","pages":"34894251336840"},"PeriodicalIF":1.3000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Otology Rhinology and Laryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00034894251336840","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Malignant mesenchymal tumors involving the parotid gland are uncommon, characteristically aggressive, and little is known with few reports documented.

Study design: Retrospective case series.

Setting: Single institution tertiary care center, 2010 to 2022.

Method: Patients were identified from an institutional parotid tumor database. Patient history, demographics, pathologic diagnosis, treatment, and follow up were documented.

Results: Eight patients were identified, 3 were males. The average age was 61 years old, and the most common tumors identified were pleomorphic sarcomas (3 patients). Presenting symptoms included: preauricular/cheek mass in 7 patients, facial pain (4), otalgia (4), aural fullness (3), and numbness (1). All patients received a parotidectomy, and 4 patients received adjuvant therapy of either radiation or chemoradiation. Post-operatively, there were 3 cases of distant recurrence, 2 cases of regional recurrence, and 1 case of local recurrence. There were 2 reports of death.

Conclusion: Malignant mesenchymal tumors of the parotid are rare, represent varied histologies. Due to their aggressive nature, surgical resection with radiation and close follow-up may be an appropriate treatment regimen in controlling the disease.

查看原文本刊更多论文

累及腮腺的间充质肿瘤的预后和特点。

背景：恶性间充质肿瘤累及腮腺是罕见的，具有侵袭性，鲜为人知，文献报道很少。研究设计:回顾性病例系列。环境：单一机构三级医疗中心，2010年至2022年。方法：从机构腮腺肿瘤数据库中筛选患者。记录患者病史、人口统计学、病理诊断、治疗和随访。结果：共确诊8例，其中男性3例。平均年龄61岁，最常见肿瘤为多形性肉瘤（3例）。主要症状包括：7例患者耳前/脸颊肿块，4例患者面部疼痛，4例患者耳痛，3例患者耳鸣，1例患者麻木。所有患者均行腮腺切除术，4例患者接受放疗或放化疗辅助治疗。术后远处复发3例，局部复发2例，局部复发1例。有两起死亡报告。结论：腮腺恶性间充质瘤少见，组织学多样。由于其侵袭性，手术切除加放疗和密切随访可能是控制疾病的适当治疗方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Otology Rhinology and Laryngology 医学-耳鼻喉科学

CiteScore

3.10

自引率

7.10%

发文量

171

审稿时长

4-8 weeks

期刊介绍： The Annals of Otology, Rhinology & Laryngology publishes original manuscripts of clinical and research importance in otolaryngology–head and neck medicine and surgery, otology, neurotology, bronchoesophagology, laryngology, rhinology, head and neck oncology and surgery, plastic and reconstructive surgery, pediatric otolaryngology, audiology, and speech pathology. In-depth studies (supplements), papers of historical interest, and reviews of computer software and applications in otolaryngology are also published, as well as imaging, pathology, and clinicopathology studies, book reviews, and letters to the editor. AOR is the official journal of the American Broncho-Esophagological Association.